Nano-X Imaging Ltd. (NNOX) Financial Ratios
7 years of historical data (2018–2024) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.55
↓-82% vs avg
5yr avg: 3.05
30Y Low1.7·High7.1
ROE
↑
-27.8%
↓+13% vs avg
5yr avg: -32.1%
30Y Low-41%·High-24%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
NNOX Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Nano-X Imaging Ltd. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $117M | $422M | $359M | $385M | $701M | $1.6B | — | — |
| Enterprise Value | $85M | $390M | $311M | $352M | $640M | $1.4B | — | — |
| P/E Ratio → | -1.97 | — | — | — | — | — | — | — |
| P/S Ratio | 10.37 | 37.41 | 36.25 | 44.94 | 537.62 | — | — | — |
| P/B Ratio | 0.55 | 2.23 | 1.84 | 1.72 | 2.40 | 7.06 | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
NNOX EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 34.59 | 31.41 | 40.99 | 490.94 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
NNOX Profitability
Margins and return-on-capital ratios measuring operating efficiency
Nano-X Imaging Ltd. earns an operating margin of -502.9%. Operating margins have expanded from -1279.0% to -502.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -27.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -94.0% | -94.0% | -66.6% | -80.2% | -116.0% | — | — | — |
| Operating Margin | -502.9% | -502.9% | -631.9% | -1279.0% | -4720.7% | — | — | — |
| Net Profit Margin | -474.3% | -474.3% | -613.6% | -1226.9% | -4739.1% | — | — | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE | -27.8% | -27.8% | -28.9% | -40.7% | -23.6% | -39.2% | — | — |
| ROA | -25.0% | -25.0% | -25.7% | -34.1% | -20.6% | -35.1% | -328.6% | -102.9% |
| ROIC | -27.9% | -27.9% | -27.7% | -39.0% | -36.9% | -2749.8% | — | — |
| ROCE | -28.4% | -28.4% | -28.5% | -40.1% | -22.7% | -39.3% | — | — |
NNOX Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $39M exceeds total debt of $7M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.17 | -0.25 | -0.15 | -0.21 | -0.92 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -213.74 | — | — | -380.80 |
Net cash position: cash ($39M) exceeds total debt ($7M)
NNOX Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Nano-X Imaging Ltd.'s current ratio of 5.63x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 4.83x to 5.63x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.63 | 5.63 | 5.71 | 4.83 | 1.80 | 49.06 | 0.48 | 0.21 |
| Quick Ratio | 5.52 | 5.52 | 5.56 | 4.69 | 1.74 | 49.06 | 0.48 | 0.21 |
| Cash Ratio | 5.24 | 5.24 | 5.31 | 4.55 | 1.68 | 47.65 | 0.40 | 0.00 |
| Asset Turnover | — | 0.05 | 0.05 | 0.03 | 0.00 | — | — | — |
| Inventory Turnover | 14.66 | 14.66 | 7.00 | 6.40 | 0.90 | — | — | — |
| Days Sales Outstanding | — | 58.39 | 54.69 | 41.57 | 294.18 | — | — | — |
NNOX Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Nano-X Imaging Ltd. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $59M | $56M | $52M | $48M | $36M | $46M | $34M |
Peer Comparison
Compare NNOX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 NNOXYou | $117M | -2.0 | — | — | -94.0% | -502.9% | -27.8% | -27.9% | — |
 HOLO | $3M | -0.3 | — | — | 22.5% | -47.6% | -7.3% | -27.3% | — |
 ATEC | $1B | -7.3 | 3487.6 | 381.1 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 PRCT | $1B | -14.4 | — | — | 63.7% | -33.7% | -24.9% | -55.7% | — |
 GEHC | $28B | 13.6 | 10.1 | 18.6 | 40.0% | 13.4% | 21.6% | 13.3% | 3.0 |
 SYK | $112B | 34.8 | 20.2 | 26.1 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 ISRG | $160B | 57.4 | 43.4 | 64.4 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 MMSI | $4B | 28.9 | 12.9 | 17.0 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 MDT | $99B | 21.5 | 14.3 | 19.2 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 BSX | $83B | 28.9 | 25.1 | 22.8 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 PHG | $26B | 24.9 | 10.7 | 24.7 | 45.2% | 8.0% | 7.8% | 6.4% | 3.2 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See NNOX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NNOX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NNOX vs HOLO
Side-by-side business, growth, and profitability comparison vs MicroCloud Hologram Inc..
Start ComparisonNNOX — Frequently Asked Questions
Quick answers to the most common questions about buying NNOX stock.
What is Nano-X Imaging Ltd.'s P/E ratio?
Nano-X Imaging Ltd.'s current P/E ratio is -2.0x. This places it at the 50th percentile of its historical range.
What is Nano-X Imaging Ltd.'s ROE?
Nano-X Imaging Ltd.'s return on equity (ROE) is -27.8%. The historical average is -32.1%.
Is NNOX stock overvalued?
Based on historical data, Nano-X Imaging Ltd. is trading at a P/E of -2.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Nano-X Imaging Ltd.'s profit margins?
Nano-X Imaging Ltd. has -94.0% gross margin and -502.9% operating margin.